211 related articles for article (PubMed ID: 19727431)
1. GENETIC VARIATION IN THE β(2)-ADRENERGIC RECEPTOR: IMPACT ON INTERMEDIATE CARDIOVASCULAR PHENOTYPES.
Hesse C; Eisenach JH
Curr Pharmacogenomics Person Med; 2008 Sep; 6(3):160-170. PubMed ID: 19727431
[TBL] [Abstract][Full Text] [Related]
2. Beta-1 and beta-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses.
Brodde OE
Pharmacol Ther; 2008 Jan; 117(1):1-29. PubMed ID: 17916379
[TBL] [Abstract][Full Text] [Related]
3. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics.
Tan S; Hall IP; Dewar J; Dow E; Lipworth B
Lancet; 1997 Oct; 350(9083):995-9. PubMed ID: 9329515
[TBL] [Abstract][Full Text] [Related]
4. Variants in the human beta 1-, beta 2-, and beta 3-adrenergic receptor genes are not associated with morbid obesity in children and adolescents.
Tafel J; Branscheid I; Skwarna B; Schlimme M; Morcos M; Algenstaedt P; Hinney A; Hebebrand J; Nawroth P; Hamann A
Diabetes Obes Metab; 2004 Nov; 6(6):452-5. PubMed ID: 15479221
[TBL] [Abstract][Full Text] [Related]
5. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure.
Port JD; Bristow MR
J Mol Cell Cardiol; 2001 May; 33(5):887-905. PubMed ID: 11343413
[TBL] [Abstract][Full Text] [Related]
6. [Study on beta 2 adrenergic receptor genetic polymorphisms in asthmatics in the people of the Han nationality of northern China].
Gao G; Wang S; Zhang J
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Feb; 23(2):93-7. PubMed ID: 11778498
[TBL] [Abstract][Full Text] [Related]
7. Clinical importance of beta-adrenoceptor polymorphisms in cardiovascular disease.
McNamara DM; MacGowan GA; London B
Am J Pharmacogenomics; 2002; 2(2):73-8. PubMed ID: 12083943
[TBL] [Abstract][Full Text] [Related]
8. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
[TBL] [Abstract][Full Text] [Related]
9. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
[TBL] [Abstract][Full Text] [Related]
10. Influence of β(2)-adrenergic receptor polymorphisms on asthma exacerbation in children with severe asthma regularly receiving salmeterol.
Giubergia V; Gravina L; Castaños C; Chertkoff L
Ann Allergy Asthma Immunol; 2013 Mar; 110(3):156-60. PubMed ID: 23548523
[TBL] [Abstract][Full Text] [Related]
11. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases.
Brodde OE
Fundam Clin Pharmacol; 2008 Apr; 22(2):107-25. PubMed ID: 18353108
[TBL] [Abstract][Full Text] [Related]
12. Beta2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations.
Carroll CL; Stoltz P; Schramm CM; Zucker AR
Chest; 2009 May; 135(5):1186-1192. PubMed ID: 19029431
[TBL] [Abstract][Full Text] [Related]
13. The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure.
Chan SW; Hu M; Tomlinson B
Expert Opin Drug Metab Toxicol; 2012 Jul; 8(7):767-90. PubMed ID: 22621216
[TBL] [Abstract][Full Text] [Related]
14. Cardiac adrenoceptors: physiological and pathophysiological relevance.
Brodde OE; Bruck H; Leineweber K
J Pharmacol Sci; 2006; 100(5):323-37. PubMed ID: 16612046
[TBL] [Abstract][Full Text] [Related]
15. Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.
Leineweber K; Heusch G
Br J Pharmacol; 2009 Sep; 158(1):61-9. PubMed ID: 19422376
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
[TBL] [Abstract][Full Text] [Related]
17. Are so many adrenergic receptor subtypes really present in domestic animal tissues? A pharmacological perspective.
Badino P; Odore R; Re G
Vet J; 2005 Sep; 170(2):163-74. PubMed ID: 16129337
[TBL] [Abstract][Full Text] [Related]
18. Association of beta2 adrenergic receptor polymorphisms and related haplotypes with triglyceride and LDL-cholesterol levels.
Petrone A; Zavarella S; Iacobellis G; Zampetti S; Vania A; Di Pietro S; Galgani A; Leonetti F; Di Mario U; Buzzetti R
Eur J Hum Genet; 2006 Jan; 14(1):94-100. PubMed ID: 16251889
[TBL] [Abstract][Full Text] [Related]
19. Beta-2-adrenergic receptor polymorphisms and changes in lipids induced by metoprolol.
Isaza CA; Henao J; Sánchez JC; Porras GL; Cardona J; Bedoya G
Pharmacology; 2007; 80(4):279-85. PubMed ID: 17671401
[TBL] [Abstract][Full Text] [Related]
20. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.
Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN
Am J Respir Crit Care Med; 2000 Jul; 162(1):75-80. PubMed ID: 10903223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
